BioSpace News Archive

Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), an integrated population health management company, announced today its consolidated financial results for the second quarter ended June 30, 2020 . “We built upon the strong momentum we generate

Cerus Corporation (Nasdaq:CERS) announced today that INTERCEPT Blood Systems disposable kit shipments have surpassed 7.5 million treatable platelet and plasma doses globally since commercial launch. “This is a significant milestone for Cerus and highlights the scope our technology has had within the transfusion industry and on the millions of patients worldwide transfused with INTERCEPT treated platelet and plasma co

Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced sales of more than $550,000 for the month of July. Sales were driven by 3D Med ANDis auto-extraction ma

Strategic Partner Sensory Cloud Advancing Toward Commercial Launch of FEND in Fall 2020 as OTC Nasal Hygiene Product for COVID-19 Received MHRA approval of the PUR1800 Ph1b clinical trial, enabling a study start in 2H 2020 Strengthened balance sheet with gross proceeds from a registered direct offering in April and a warrant exercise transaction in July

Valle del Sol and Mercy Care join CVS Health to raise awareness about new COVID-19 rapid testing site

Upsher-Smith Laboratories, LLC (Upsher-Smith) and AmbioPharm, Inc. (AmbioPharm) today announced that the companies have entered into a partnership agreement to develop and market Corticotropin Injection in the U.S. The market for adrenocorticotropic hormone or ACTH (brand Acthar ® Gel*) is currently

Invacare Corporation to Participate in the 5 th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven” or the “Company”) announced that it entered into a $500 million non-dilutive term loan financing facility with Six

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that TBP common shares and warrants are now listed on the TSX (the “Common Shares”) and (the “Warrants”)

Innovative Regulatory Risk Advisors LLC is a certified minority owned business and SBA 8 firm that provides regulatory compliance, risk management and business advisory capabilities to B2Band B2G clientele in Banking and Financial Services, Healthcare, Government, Energy and Technology.